| Dedifferentiated Liposarcoma studied in …STUDIED_INderived35 of 35show fewer |
|---|
| → studied in | NCT06498648Phase 1/Phase 2 · recruiting Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma · condition mapped CURATED_BROADER · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06422806Phase 3 · recruiting Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas · condition mapped CURATED_BROADER · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05694871Phase 2 · active not recruiting Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma · condition mapped CURATED_BROADER · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06025747Phase 1 · recruiting A Phase 1 Study of Neoadjuvant Abemaciclib in Combination With Radiation Therapy for Liposarcomas · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06843967Phase 1/Phase 2 · recruiting A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07802652Phase 2 · not yet recruiting Doxorubicin With or Without DT-7012 in Advanced Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03307616Phase 2 · active not recruiting Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05711615Phase 1 · recruiting Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma · condition mapped CURATED_BROADER · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06389799Phase 2 · recruiting A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI) · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06975293Phase 1/Phase 2 · recruiting STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06239272Phase 1/Phase 2 · recruiting NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07741877Phase 2 · not yet recruiting A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04668300Phase 2 · active not recruiting Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma · condition mapped CURATED_BROADER · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06789172Phase 1 · recruiting A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02846987Phase 2 · active not recruiting Study of Abemaciclib in Dedifferentiated Liposarcoma · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04420975Phase 1 · active not recruiting Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma · condition mapped CURATED_BROADER · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05218499Phase 2/Phase 3 · completed Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07432932recruiting Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04794127Phase 2 · completed Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone. · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06058793Phase 3 · completed Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05496569Phase 2 · terminated TQB3616 Capsules in the Treatment of Dedifferentiated Liposarcoma · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05886634Phase 2 · active not recruiting A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04242238Phase 1 · completed Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06115681completed Real-world Study of Dedifferentiated Liposarcoma Patients in China · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05580588Phase 2 · terminated Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04979442Phase 3 · terminated Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06694324Phase 2 · not yet recruiting First-line Treatment of Advanced/unresectable DDLPS · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03604783Phase 1 · terminated Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06526897NA · not yet recruiting Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02500797Phase 2 · completed Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02606461Phase 2/Phase 3 · completed Selinexor in Advanced Liposarcoma · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01913652Phase 2 · completed Ph II Cabazitaxel DD Liposarcoma · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03989596Phase 2 · unknown Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03651375Phase 2 · unknown Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00969917Phase 2 · withdrawn Study Evaluating the Efficacy and Safety of IPI 504 in Patients With Advanced Dedifferentiated Liposarcoma · condition mapped ONTOLOGY_EXACT · 35 trials mapped (20 active) | — | — | Dedifferentiated Liposarcoma | 1 | Observed | clinicaltrials | graph → |